DR. FARIBA NAVID, MD

Plain English
This research paper examines the connection between a specific protein, HLA-B27, and a group of inflammatory diseases called spondyloarthritis (SpA), which can cause pain and affect joints and other body parts. The study highlights three main theories on how HLA-B27 might lead to these conditions, including how it could trick the immune system into attacking the body, causing inflammation and possibly damaging bones. Understanding these mechanisms is crucial because it can help improve diagnosis and treatment for people suffering from these painful diseases. Who this helps: This benefits patients with spondyloarthritis and healthcare providers.

Plain English
This study looked at a type of childhood cancer called non-rhabdomyosarcoma soft tissue sarcomas (NRSTS), which make up about 4% of all childhood cancers and have poor outcomes for patients, especially when the disease has spread or come back. Researchers from the Children's Oncology Group found that immune checkpoint inhibitors and tyrosine kinase inhibitors are promising treatments worth studying further in clinical trials. This is important because it can lead to better treatment options for children with this rare and challenging type of cancer. Who this helps: This helps children with non-rhabdomyosarcoma soft tissue sarcomas and their doctors.

Plain English
This study looked at a new treatment approach for high-risk Ewing sarcoma, a type of bone cancer that typically has poor outcomes. Researchers tested a combination of four drugs (irinotecan, temozolomide, and temsirolimus) before standard chemotherapy and evaluated its effectiveness. While only three out of 12 patients showed some improvement in their tumors, all patients had a noticeable reduction in tumor size (an average decrease of about 32.5%) and less cancer activity, which is encouraging. Who this helps: This research benefits patients with high-risk Ewing sarcoma and their doctors by exploring potential new treatment options.

Plain English
Researchers studied MEHMO syndrome, a rare genetic condition linked to issues with the brain and hormones, characterized by traits like mental disability, seizures, and obesity. They found that changes in the EIF2S3 gene are responsible for this syndrome and recommended classifying it among other similar disorders to improve understanding and treatment. This matters because better classification can lead to more effective diagnosis and therapies for affected individuals. Who this helps: Patients with MEHMO syndrome and their families.

Plain English
This study focused on melorheostosis, a rare condition that leads to painful bone overgrowth. Researchers found that cells from affected patients grow faster because of specific changes in their biology, showing 30% more proliferative cells compared to unaffected ones. By using a drug called palbociclib, they were able to slow down this excessive cell growth and reduce abnormal bone formation. Who this helps: This benefits patients with melorheostosis by presenting a potential treatment option.

Plain English
This study looked at over 8,000 heart surgery patients to find out if using non-red blood cell blood products, like platelets and plasma, affects survival after surgery. The results showed that there was no significant difference in death rates between patients who received these products (1.5% died) and those who didn't (1.0%). However, patients receiving non-red blood products had higher rates of reoperations and prolonged ventilation. Who this helps: This information is useful for doctors and healthcare providers caring for heart surgery patients.

Plain English
This study looked at 552 patients who had surgery for a type A aortic dissection, focusing on how long they needed mechanical ventilation after the procedure. The researchers found that patients on mechanical ventilation for more than 48 hours had a significantly higher in-hospital death rate of 30%, compared to only 5.2% for those ventilated for 12 hours or less. This is important because it highlights the risks associated with prolonged mechanical ventilation, suggesting it may lead to worse long-term survival outcomes for these patients. Who this helps: This information benefits patients and their doctors by highlighting the importance of reducing ventilation time when possible.

Plain English
This study looked at two different surgical approaches for patients who experienced a serious condition called acute type A aortic dissection: preserving the aortic root versus replacing it entirely. Researchers analyzed data from 601 surgeries and found that both approaches had similar outcomes after an average follow-up of over six years, including no significant differences in complications or survival rates. Specifically, the long-term survival rates were nearly identical, with a slight increase in risk for the replacement group (1.13), but this was not statistically significant. Who this helps: This benefits patients undergoing surgery for acute type A aortic dissection by offering options that are equally effective in terms of survival and recovery.

Plain English
This study looked at patients who underwent emergency surgery for a serious heart condition called acute type A aortic dissection and considered how malperfusion syndrome (a problem where blood isn't flowing properly) affected their outcomes. Among 467 patients, those with malperfusion syndrome had a much higher in-hospital mortality rate of 21.5% compared to 5.7% for those without it. The findings indicate that patients with malperfusion syndrome face significant risks during and after surgery, highlighting the need for quick treatment to improve their chances of survival. **Who this helps:** This helps patients with acute type A aortic dissection, especially those with malperfusion syndrome.

Plain English
This study looked at two methods of connecting a tube to the heart (cannulation) during surgery for a serious condition called acute type A aortic dissection. It involved 577 patients and found that while central cannulation was used in about 85% of the cases and had a slightly lower mortality rate of 9.8%, there was no significant difference in long-term survival between the methods. This is important because it helps doctors understand that both central and peripheral cannulation are safe options for this surgery, providing flexibility in treatment choices. Who this helps: This helps patients undergoing surgery for aortic dissection and their doctors.

Plain English
This study created a new test to find important genetic changes, called fusions, in various pediatric tumors, including blood cancers and brain tumors. They tested this new method on 50 samples and found that it accurately identified known fusions in 94% of the cases. This is important because it helps doctors detect critical genetic information that can guide treatment for young patients with difficult-to-diagnose cancers. Who this helps: Pediatric cancer patients and their doctors.

Plain English
This study looked at how a specific protein (CHOP) affects gut inflammation in rats that have a genetic risk factor for a type of arthritis called spondyloarthritis. The researchers found that when CHOP was absent, inflammation in the gut got worse rather than better, showing higher levels of other inflammatory markers. This is important because it suggests that CHOP might actually help protect against gut problems in these patients. Who this helps: This helps patients with spondyloarthritis and their doctors understand how to manage related gut inflammation.

Plain English
This study reviewed how desmoid tumors (DT), which are rare and can aggressively grow, are currently treated. The researchers gathered over 90 experts to update treatment guidelines based on the latest findings, including the use of new medical agents like nirogacestat, which is the first drug approved specifically for DT. They emphasized that treatment should be personalized and managed by specialized centers to ensure the best outcomes for patients. Who this helps: This helps patients with desmoid tumors and their healthcare providers.

Plain English
This study looked at how complete revascularization during heart bypass surgery affects patient health outcomes. Among 3,356 patients who had the surgery, those who received complete revascularization had a better chance of surviving for one year (94.6% vs. 92.5%) and five years (86.5% vs. 82.1%) compared to those with incomplete revascularization. Additionally, complete revascularization was linked to a lower risk of significant heart and brain-related problems at both one year (89.2% vs. 84.2%) and five years (72.5% vs. 66.7%). Who this helps: This information benefits patients undergoing coronary artery bypass surgery, as it highlights the importance of complete revascularization for better long-term health.

Plain English
This study looked at patients undergoing aortic arch surgery using a method that temporarily stops blood circulation while keeping the body cold. Researchers monitored brain activity to see if any changes could predict early brain problems or death within 48 hours after the surgery. They found that out of 563 patients, those who had changes in brain activity were significantly more likely to experience severe complications, with a death rate of 22.7% compared to just 4.3% for those without changes. Who this helps: This helps patients undergoing aortic arch surgery and their doctors by highlighting the importance of monitoring brain activity for better outcomes.

Plain English
This study looked at how patients do after a specific heart surgery called hemiarch replacement, which involves cooling the body and restoring blood flow to the brain during the procedure. Researchers tracked 500 patients from 2010 to 2018 and found that the overall death rate during surgery was 6.4%, with 4.6% suffering a stroke. Five years later, 84.4% of all patients were still alive, with slightly higher survival rates for those with aneurysm (88.0%) compared to those with acute aortic dissection (80.5%). This matters because it shows that the surgery has low risks and similar outcomes for different types of aortic diseases, making it a reliable option for treatment. Who this helps: This helps patients with aortic diseases who may require this type of surgery.

Plain English
This study looked at the outcomes of patients who had surgery to replace the aortic root, focusing on those who had the surgery for the first time versus those who had already undergone this procedure before. Researchers examined 893 patients and found that both groups had similar survival rates; after five years, about 74% of first-time patients survived compared to roughly 73% of repeat patients. This means that having surgery again on the aortic root does not increase risks or decrease survival compared to having the surgery for the first time. Who this helps: This information benefits patients needing aortic root surgery, especially those who may require a second operation.

Plain English
This study looked at the long-term effects of a heart rhythm problem called postoperative atrial fibrillation (AF) after heart surgery. Among over 12,000 patients, those who developed AF after surgery had significantly higher rates of complications like reoperation (12.1% vs. 6.8%), pneumonia (6.6% vs. 2.4%), and renal failure (6.9% vs. 3.4%) compared to those who did not have AF. These patients also had a higher risk of dying and being readmitted to the hospital later, showing that AF after surgery leads to more health issues and lower survival rates. Who this helps: This research benefits patients who undergo heart surgery, helping them and their doctors understand the risks associated with postoperative atrial fibrillation.

Plain English
This study looked at the effects of aortic root enlargement (ARE) when combined with aortic valve replacement (AVR) in patients. Out of 2,371 patients, 131 had AVR with ARE, which led to a smaller valve being used and resulted in a longer hospital stay (7 days vs. 6 days) and higher rates of complications like acute kidney injury (6.1% vs. 2.5%). However, the overall survival rates were similar for both groups, indicating that ARE can be safely added to AVR to help patients with smaller heart valves. Who this helps: This research benefits patients with small aortic valves who require valve replacement.

Plain English
This study looked at patients with multi-vessel coronary artery disease to compare outcomes between those who received coronary artery bypass surgery (CABG) using multiple arteries and those who had a non-surgical procedure called percutaneous coronary intervention (PCI). Researchers found that patients who underwent CABG had a lower risk of death at 30 days (0.8% compared to 2.9% for PCI patients) and better long-term survival (87.1% for CABG vs. 74.6% for PCI) over nearly five years. This is important because it shows that CABG with multiple arteries leads to fewer serious complications and improved survival rates compared to PCI. Who this helps: This helps patients with multi-vessel coronary artery disease and their doctors in making better treatment decisions.

Plain English
This study looked at the relationship between a specific protein called ERAP1 and a molecule known as HLA-B27 in rats with a type of arthritis called spondyloarthritis. Researchers found that when the ERAP1 protein was absent, it significantly reduced the occurrence of arthritis in these rats by two-thirds while also improving how well HLA-B27 was functioning. This is important because it suggests that changes in ERAP1 might help lower the risk of certain inflammatory arthritis conditions in humans. Who this helps: This benefits patients at risk for spondyloarthritis and their doctors by providing insights that could lead to new treatments.

Plain English
This study looked at how monitoring brain activity during heart surgery can help predict the risk of having a stroke afterward. Researchers analyzed 620 patients and found that about 5.3% had strokes within 30 days of surgery. They discovered that diabetes and permanent changes in brain activity during the surgery were strong indicators of a higher risk for stroke, meaning that patients without these changes had a better chance of survival after the operation. Who this helps: This helps patients undergoing cardiac surgery and their doctors in assessing stroke risk.

Plain English
This study explored a new way to analyze blood samples from children with solid tumors to better understand their cancer by looking for changes in their DNA. Researchers examined blood from 73 patients and found that 70% of those diagnosed without prior treatment had signs of tumor DNA in their blood. This study is important because it shows that this blood test can effectively identify cancer-related changes and specific genetic fusions in various tumors, helping guide treatment decisions for young patients. Who this helps: This benefits pediatric cancer patients and their doctors by providing a less invasive method to monitor tumors and tailor therapies.

Plain English
Researchers studied the combination of two drugs, ganitumab and dasatinib, to treat a type of cancer called rhabdomyosarcoma (RMS) in young patients. Out of 13 participants, one experienced a significant reduction in their tumor, and another's disease remained stable for six cycles of treatment. The treatment was generally safe, with a 22% success rate at five months, indicating it may help some patients manage their condition better. Who this helps: This helps young patients with relapsed or hard-to-treat rhabdomyosarcoma.

Plain English
The study focused on a rare bone disorder called classical melorheostosis, which causes excessive bone growth and pain due to mutations in a specific gene (MAP2K1). Researchers created stem cells from patients’ skin cells and found that these cells produced higher levels of a growth factor called VEGF, which promotes bone formation. They discovered that blocking VEGF reduced bone development, suggesting that targeting VEGF may lead to new treatments for this condition. Who this helps: This research benefits patients with melorheostosis and other rare bone disorders.

Plain English
This study looked at the best surgical methods for treating lung tumors in young patients with osteosarcoma, a type of bone cancer. Researchers examined 61 patients and found that although the survival rates were similar regardless of whether surgeons used thoracotomy (a large incision) or thoracoscopy (a less invasive method), the thoracotomy approach led to more complications like pain and longer hospital stays. This matters because it suggests that less invasive surgery may be just as effective but safer for young cancer patients. Who this helps: This helps young cancer patients and their doctors in making better surgical choices.

Plain English
This study examined a rare type of cancer called malignant rhabdoid tumor (MRT) in a 14-year-old girl, which usually affects younger children. The tumor measured about 8x8x6.5 cm and was found near her adrenal gland. The findings highlighted unique genetic mutations and characteristics of the tumor that are not typically seen, providing more information about this aggressive disease. Who this helps: This research helps doctors better understand and diagnose rare tumors in young patients.

Plain English
This study looked at how well two types of heart valves—stented and stentless bioprosthetic valves—perform after aortic root replacement surgery. Researchers found that 53.4% of 455 patients received stentless valves, but both groups had similar results in terms of survival and needing additional surgeries over an average follow-up of 4.41 years. While the stentless valves showed better blood flow measurements, the overall impact on long-term health or the need for further procedures wasn't clear yet. Who this helps: This research benefits patients undergoing aortic root replacement by providing insights into their valve options.

Plain English
This study looked at a rare tumor called kaposiform hemangioendothelioma (KHE) that develops in the bones of children and teenagers. Researchers examined several cases and found that KHE in the bone is not common, but it can lead to serious complications in about 70% of patients. Understanding this tumor is important because it helps doctors recognize and manage this condition better. Who this helps: This benefits doctors and healthcare providers treating affected children and adolescents.

Plain English
This study looked at two treatment options for elderly patients (75 years and older) with multiple blocked heart arteries: coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). The researchers followed 536 patients and found that those who had CABG had a significantly higher chance of being completely free of artery blockages (86.8% compared to 21.8%) and better 5-year survival rates (73.8% versus 60.1%) compared to those who had PCI. This is important because it shows that CABG could offer better long-term survival for older patients with complex heart issues, even though it requires a longer hospital stay. Who this helps: This information benefits elderly patients with multivessel coronary artery disease and their doctors.

Plain English
This study looked at the results of two heart procedures—coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI)—in patients with multiple blocked arteries. Among 5,836 patients, those deemed low risk had a lower chance of dying within five years: 10.9% for CABG and 21.6% for PCI, compared to much higher rates of 40.1% and 61.8% respectively for those at intermediate to high risk. These findings are significant because they help doctors decide which treatment may be best for individual patients based on their risk levels. Who this helps: This information helps patients and doctors choose the best heart treatment based on risk.

Plain English
This study looked at cells from patients with melorheostosis, a rare bone disease that affects blood vessel growth. Researchers found that the skin cells from these patients produced more of a substance called VEGF, which promotes blood vessel formation, compared to normal cells. Specifically, when healthy cells were treated with factors from the affected fibroblasts, it led to a significant increase in their blood vessel growth activity, indicating that targeting these pathways could help manage the disease. Who this helps: This benefits patients with melorheostosis and their doctors by providing potential new treatment options.

Plain English
This study looked at the long-term effects of using mechanical versus bioprosthetic (tissue) valves in patients who had surgery to replace the aortic root, a part of the heart. Among 701 patients evaluated, those with mechanical valves had better survival rates—only 2.4% died after surgery compared to 7.9% of those with bioprosthetic valves. This matters because choosing the right type of valve can significantly impact a patient's long-term health and survival. Who this helps: Patients undergoing aortic root replacement.

Plain English
This study looked at the long-term effects of acute renal failure (ARF) on patients after they had surgery for an aortic tear called acute type A aortic dissection. Out of 601 patients, 85 (14.1%) developed ARF, which was linked to worse health outcomes, including a death rate that was 2.74 times higher over several years compared to those who did not have ARF. This matters because it shows that ARF significantly worsens survival chances after this type of surgery, highlighting the need for better care to prevent it. Who this helps: This helps patients undergoing aortic surgery and their doctors by emphasizing the importance of managing kidney function during recovery.

Plain English
This study looked at how often patients being transferred to specialized heart hospitals for serious aortic conditions were misdiagnosed before their transfer. Out of over 3,700 emergency cases, about 11% were misdiagnosed, with some patients incorrectly labeled as having a life-threatening condition when they did not. This misdiagnosis usually happened due to errors in interpreting medical imaging, which suggests that training improvements could enhance the accuracy of initial diagnoses. Who this helps: This helps patients at risk of serious aortic issues and the doctors involved in their care.

Plain English
This study looked at how effective a procedure called transcatheter aortic valve implantation (TAVI) is for patients with severe aortic stenosis who also experience serious bleeding in the digestive system. Out of 1,192 patients, 164 (about 14%) had severe digestive bleeding, and 79% of those patients saw their bleeding problems improve after the procedure. Importantly, patients with severe bleeding had similar survival rates after 30 days compared to those without bleeding issues, indicating TAVI is both safe and beneficial for this group. Who this helps: Patients with severe aortic stenosis and gastrointestinal bleeding.

Plain English
This study looked at two methods used to protect the brain during a type of heart surgery called aortic hemiarch reconstruction. Researchers compared deep hypothermic circulatory arrest (freezing the body temporarily) with a combination of this method plus retrograde cerebral perfusion (a technique to keep blood flowing to the brain) in 565 patients. They found that both methods had similar success rates, with very low death rates of 0.8% and 2.7% for elective surgeries, and slightly higher but comparable rates of 11.6% and 9.4% for surgeries on acute aortic dissections. Who this helps: This research benefits doctors and their patients undergoing aortic surgery by showing that both methods are equally effective in protecting the brain.

Plain English
This study focused on desmoid tumors (DT), which are rare and can cause discomfort in children but do not spread to other parts of the body. The researchers found that traditional treatments like surgery can lead to high recurrence rates, and some non-surgical treatments, such as targeted drugs, can be effective. The review highlights the importance of monitoring the tumors without immediate treatment since some children can experience stability or even improvement without intervention. Who this helps: This helps children with desmoid tumors and their families by providing alternatives to invasive treatments.

Plain English
This study looked at the differences in recovery after surgery for a serious heart condition called acute type A aortic dissection, comparing men and women. Researchers examined data from 601 patients who had this surgery between 2007 and 2021. They found that while women had a slightly higher rate of early deaths (13.8% vs. 9.4% for men), the difference wasn't significant, and overall survival rates after surgery were similar for both sexes. Who this helps: This research benefits both patients and doctors by highlighting that men and women can expect similar outcomes after this type of surgery.

Plain English
This study looked at a new treatment combining chemotherapy with an experimental drug called hu14.18K322A for children newly diagnosed with high-risk neuroblastoma, a serious cancer. The results showed that 66.7% of the children had a positive response after the first two treatment cycles, with tumor size decreasing by a median of 75%. After three years, 73.7% of the children remained cancer-free, and 86% were alive, highlighting the treatment's potential to improve outcomes significantly. Who this helps: This benefits children with high-risk neuroblastoma and their families, as well as the doctors treating them.

Plain English
This study looked at patients who needed a permanent pacemaker (PPM) after having heart valve surgery to see how it affected their recovery over five years. Out of 3,602 patients analyzed, 175 (about 5%) required a PPM, and these patients had worse initial health (higher risk scores) and fewer complications, but interestingly, using a PPM did not lead to higher death rates or hospital readmissions compared to those who didn't receive one. This matters because it indicates that while needing a PPM can signal existing health issues, it doesn’t necessarily worsen the overall survival or hospital stay after valve surgery. Who this helps: This helps patients who undergo valve surgery and their doctors in understanding the impact of needing a pacemaker on recovery.

Plain English
This study looked at the effects of keeping patients slightly cooler (mild hypothermia) versus normal temperature (normothermia) during heart surgery with a heart-lung machine. The research involved 6,525 patients, with results showing no significant difference in long-term survival rates (about 82.6% for mild hypothermia and 81.6% for normothermia) after an average follow-up of 4.4 years. However, patients who were cooled had a higher risk of kidney failure after surgery (3.7% vs. 2.4%) and spent more time in the intensive care unit. Who this helps: This information benefits patients undergoing cardiac surgery and their doctors as they consider the best temperature management during procedures.

Plain English
This study focused on finding new treatments for osteosarcoma, a type of bone cancer that mainly affects children and young adults. Researchers identified promising new drugs, including multitargeted tyrosine kinase inhibitors and various immunotherapies, with multitargeted tyrosine kinase inhibitors being prioritized for further testing in a major clinical trial. This is important because patients with metastatic or relapsed osteosarcoma have had very few treatment options for years, and these new agents could lead to better outcomes. Who this helps: Patients with osteosarcoma and their families.

Plain English
This study looked at two ways of using the right internal mammary artery (RIMA) during heart surgery known as coronary artery bypass grafting (CABG). The research included 667 patients, with 422 using the RIMA as a free graft and 245 using it in its original location; it found that the long-term risks and survival rates were quite similar: 5-year mortality was 6.6% for free RIMA and 4.1% for in situ RIMA, with no significant differences in heart-related complications. This is important because it gives surgeons the flexibility to choose either method without worrying about compromising patient outcomes. Who this helps: This helps surgeons and heart surgery patients by providing options that maintain safety and effectiveness.

Plain English
This study looked at whether having cardiac surgery in the afternoon leads to worse outcomes compared to morning surgeries. The researchers analyzed data from nearly 8,000 patients and found that both groups had similar rates of complications and survival—98% were alive 30 days after surgery, with only a slight difference in mortality rates (1.83% for morning surgeries vs. 2.21% for afternoon). This matters because it shows that the time of day for surgery doesn’t negatively impact overall health outcomes, allowing for more flexibility in scheduling. Who this helps: Patients undergoing cardiac surgery.

Plain English
This study looked at over 1,000 patients who received a transcatheter aortic valve replacement (TAVR) to understand their hospital readmission rates and outcomes after the procedure. Researchers found that 34.4% of patients were readmitted for non-cardiac issues, such as infections and gastrointestinal problems, while 20.5% were readmitted for heart-related issues. Readmissions to the intensive care unit (ICU) were particularly concerning, as they were linked to a higher risk of death. Who this helps: This information benefits patients and doctors by highlighting the common risks associated with TAVR and informing better post-procedure care.

Plain English
This study looked at a rare genetic disorder called Niemann-Pick disease, type C1, which causes severe brain and movement problems. Researchers discovered that a certain protein, called Slc1a3, that helps manage glutamate levels (a chemical in the brain), is not working properly in mice with this disease. They found that using a drug called riluzole improved the survival of these mice by 12%, indicating it could be a new treatment option for patients. Who this helps: This helps patients with Niemann-Pick disease, type C1 and their doctors.

Plain English
This study looked at patients undergoing heart surgery (coronary artery bypass grafting, or CABG) who also had severe narrowing of their carotid arteries (sCAS). Among nearly 5,500 patients, those with sCAS faced a higher risk of suffering a stroke during or shortly after surgery (4.4% compared to 1.2% for those without sCAS) and had lower survival rates after one and five years. It highlights that having sCAS is linked to increased risk of stroke and death, especially for individuals with a history of stroke. Who this helps: This research benefits patients and doctors by identifying risks during heart surgery that can inform treatment decisions.